Trigeminal Neuralgia
                     Trigeminal Neuralgia
Presented by- DelveInsight Business Research

What is Trigeminal Neuralgia?
Trigeminal Neuralgia (TN), also known as tic douloureux, is a chronic pain 
condition that affects the trigeminal or fifth cranial nerve, one of the most 
widely distributed nerves in the head. It is a form of neuropathic pain 
(pain associated with nerve injury or nerve lesion), and categorized in 
two types: primary (idiopathic) and secondary.
The typical or “classic” form of the disorder called TN1 causes extreme, 
sporadic, sudden burning or shock-like facial pain that lasts anywhere 
from a few seconds to as long as two minutes per episode. These 
attacks can occur in quick succession, in volleys lasting as long as 2 h. 
The “atypical” form of the disorder called TN2 is characterized by 
constant aching, burning, stabbing pain of somewhat lower intensity 
than Type 1, as in the Trigeminal Neuralgia Market
Both forms of pain may occur in the same person, sometimes at the 
same time. The intensity of pain can be physically and mentally 
incapacitating.
TN occurs most often in people over age 50, although it can occur at 
any age, including infancy. The possibility of TN being caused by 
multiple sclerosis increases when it occurs in young adults. 
The incidence of new cases is approximately 12 per 100,000 people per 
year; the disorder is more common in women than in men.
How Many Regions Are 
Covered?
● The US
● EU5 (Germany, France, Italy, Spain, 
and the United Kingdom)
● Japan
TN is associated with a variety of conditions. TN 
can be caused by a blood vessel pressing on 
the trigeminal nerve as it exits the brain stem; 
this compression causes the wearing away or 
damage to the protective coating around the 
nerve (the myelin sheath). TN symptoms can 
also occur in people with multiple sclerosis, a 
disease that causes deterioration of the 
trigeminal nerve’s myelin sheath.
In rare cases, symptoms of TN may be caused by nerve 
compression from a tumor, or a tangle of arteries and veins 
called an arteriovenous malformation. Injury to the 
trigeminal nerve (perhaps the result of sinus surgery, oral 
surgery, stroke, or facial trauma) may also produce 
neuropathic facial pain.
Source:- Trigeminal Neuralgia Market Report
KOL- Views- Trigeminal 
Neuralgia
       To keep up with the market trends, we take KOLs and SME’s opinion working 
in Trigeminal Neuralgia domain through primary research to fill the data gaps 
and validate our secondary research. Their opinion helps to understand and 
validate current and emerging therapies treatment patterns or Trigeminal 
Neuralgia market trend. This will support the clients in making informed 
business decisions by identifying the overall scenario of the market and the 
unmet needs.
What is the Trigeminal Neuralgia 
Report Scope?
● The report covers the descriptive overview of Trigeminal Neuralgia (TN), explaining its causes, 
signs and symptoms, pathophysiology, diagnosis and currently available therapies
● Comprehensive insight has been provided into the Trigeminal Neuralgia (TN) epidemiology and 
treatment in the 7MM
● Additionally, an all-inclusive account of both the current and emerging therapies for Trigeminal 
Neuralgia (TN) are provided, along with the assessment of new therapies, which will have an 
impact on the current treatment landscape
● A detailed review of Trigeminal Neuralgia (TN) market; historical and forecasted is included in the 
report, covering drug outreach in the 7MM
● The report provides an edge while developing business strategies, by understanding trends 
shaping and driving the global Trigeminal Neuralgia (TN) market
What are the Trigeminal Neuralgia 
Market 
Report Highlights?
● In the coming years, Trigeminal Neuralgia (TN) market is set to change due to the rising 
awareness of the disease, and incremental healthcare spending across the world; which would 
expand the size of the market to enable the drug manufacturers to penetrate more into the 
market
● The companies and academics are working to assess challenges and seek opportunities that 
could influence Trigeminal Neuralgia (TN) R&D. The therapies under development are focused on 
novel approaches to treat/improve the disease condition      
● Major players are involved in developing therapies for Trigeminal Neuralgia (TN). Launch of 
emerging therapies will significantly impact the Trigeminal Neuralgia (TN) market
● A better understanding of disease pathogenesis will also contribute to the development of novel 
therapeutics for Trigeminal Neuralgia (TN) o by identifying the overall scenario of the research 
and development activities
[email protected]
[email protected]
+91-9650213330
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
DFola tYiconu,  aHnda invfoeg rAapnhiycs  Q& uimeagsetsi obyn  or 
Freepik
Query?
Please keep this slide for attribution
Than
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
Flaticon, and infographics & images by 
kFresepik !